This review summarizes the biological properties of the junctional epithelium, focusing on its
developmental aspects, wide intercellular spaces and desmosomes, dense granules …

Objectives This study sought to evaluate direct oral anticoagulant (DOAC) outcomes (vs.
warfarin) in patients with atrial fibrillation (AF) across body mass index (BMI) categories …

Obesity, hypertension, insulin resistance, and dyslipidemia are all clusters of an entity called
“Metabolic Syndrome”. The global trends of this syndrome's incidence/prevalence continue …

The impact of obesity on the prognosis of atrial fibrillation (AF) remains controversial. We
conducted an exposure‐effect meta‐analysis of prospective studies to clarify the relationship …

Background The effects of anticoagulants at extremes of body weight (BW) are not well
described. The aim of this study was to analyze the pharmacokinetics/pharmacodynamics …

Objective: To review literature on the use of direct-acting oral anticoagulants (DOACs) in
patients with high body weight (BW) and/or high body mass index (BMI) and to make …

Objective Obesity has traditionally been considered a risk factor for ischemic stroke.
However, some clinical observations have reported a complex relationship between patients …

BACKGROUND: The efficacy and safety of non–vitamin-K antagonist oral anticoagulants
(NOACs) across the spectrum of body mass index (BMI) and body weight (BW) remain …

Atrial fibrillation (AF) is the most common cardiac arrhythmia. AF increases the risk of stroke,
heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both …

Background Obesity and weight gain are established risk factors for atrial fibrillation (AF).
Objective The purpose of this study was to investigate whether bodyweight variability is also …